Skip to content

Tools

Reference

Learn

Reference

Glossary

Plain-language definitions of the terms you meet on a peptide label, a syringe and a reconstitution guide. The glossary explains what words mean. It does not publish doses: those come from your clinician, pharmacy, product instructions, or research protocol.

65 terms

A

B

  • Sterile water that contains benzyl alcohol as a preservative, which inhibits bacterial growth in the water. It is used as a diluent for multi-use vials.

  • A preservative added to bacteriostatic water that inhibits the growth of bacteria. It is what separates bacteriostatic water from plain sterile water.

  • The fraction of a substance that reaches the bloodstream in active form. It depends on how a compound enters the body and on how the body processes it.

  • BPC-157

    A 15-amino-acid peptide derived from a gastric protein, studied in animal models for soft-tissue and gut healing. There is no published human pharmacokinetic data. This compound is sold for laboratory research and is not approved by the FDA for human use. Being listed here does not mean it is approved, recommended, or evaluated for safety or efficacy.

C

D

E

  • Endotoxin

    A fragment of the outer wall of certain bacteria that can cause fever and inflammation if it enters the body, even when the bacteria are dead. Injectable products are tested for it.

F

G

H

  • Half-life

    The time it takes for the amount of a substance in the body to fall by half. It describes how quickly the body clears a compound, not how long an effect lasts.

  • hCG

    Human chorionic gonadotropin, a hormone approved for ovulation induction and hypogonadotropic hypogonadism, supplied as a lyophilized powder and labelled in international units rather than by weight. FDA-approved prescription products containing hCG exist (Pregnyl, Novarel). Compounded and research formulations are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness or quality.

  • HPLC

    High-performance liquid chromatography, a laboratory method that separates the components of a sample so each can be measured. It is the method most often used to report a peptide’s purity.

I

  • The marks on an insulin syringe barrel. A unit measures volume on the syringe’s scale, not the amount of compound; how much compound sits in one unit depends on the concentration of the liquid.

  • Intramuscular

    Into a muscle. The word describes where in the body an injection is placed; this glossary does not recommend where to inject any compound.

  • Still being tested in clinical trials and not approved for sale as a medicine. An investigational compound has not yet been shown to regulators to be safe and effective for its intended use.

  • Ipamorelin

    A selective growth hormone secretagogue, noted for minimal effect on cortisol and prolactin relative to older GHRPs. This compound is sold for laboratory research and is not approved by the FDA for human use. Being listed here does not mean it is approved, recommended, or evaluated for safety or efficacy.

  • A measure of a substance’s biological activity rather than its weight. How many micrograms make one IU differs from substance to substance, so IU cannot be converted to mg without that substance’s own conversion.

L

  • A lump of thickened fatty tissue that can form under the skin at a spot where injections are given repeatedly. It was first described in people who inject insulin.

  • Liraglutide

    A GLP-1 receptor agonist approved for weight management and for type 2 diabetes. FDA-approved prescription products containing Liraglutide exist (Saxenda, Victoza). Compounded and research formulations are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness or quality.

  • Freeze-drying: freezing a product and then removing the ice by sublimation under vacuum, leaving a dry, porous cake or powder.

  • A dry powder made by freeze-drying, which removes water at low temperature. Many peptides are supplied this way because removing water slows chemical breakdown.

M

P

R

S

  • Semaglutide

    A long-acting GLP-1 receptor agonist approved for type 2 diabetes and chronic weight management. FDA-approved prescription products containing Semaglutide exist (Ozempic, Wegovy, Rybelsus). Compounded and research formulations are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness or quality.

  • The rubber closure in the top of a vial. A needle can pierce it, and it reseals as the needle is withdrawn so the contents stay enclosed.

  • Sermorelin

    A GHRH analog historically approved for diagnostic use. No FDA-approved Sermorelin product is currently marketed in the US. Some clinicians prescribe it as a compounded preparation; compounded drugs are not FDA-approved.

  • Sterile

    Free from living microorganisms. Sterility is a property of how a product was made and sealed, and opening or puncturing a container can end it.

  • Sterile water

    Water free of living microorganisms, with no preservative added. Without a preservative it does not inhibit bacterial growth once a container has been opened.

  • Subcutaneous

    Beneath the skin, in the layer of fat between the skin and the muscle. The word describes where in the body an injection is placed.

T

  • TB-500

    A synthetic fragment of a longer natural thymus protein, studied for cell migration and tissue repair. Published human trials used the full-length protein, not this fragment. This compound is sold for laboratory research and is not approved by the FDA for human use. Being listed here does not mean it is approved, recommended, or evaluated for safety or efficacy.

  • Tesamorelin

    A GHRH analog indicated for the reduction of excess visceral abdominal fat in HIV-associated lipodystrophy. FDA-approved prescription products containing Tesamorelin exist (Egrifta). Compounded and research formulations are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness or quality.

  • A thymus-derived peptide approved in a number of countries as an immune modulator, notably for hepatitis B and C. No FDA-approved Thymosin Alpha-1 product is currently marketed in the US. Some clinicians prescribe it as a compounded preparation; compounded drugs are not FDA-approved.

  • Tirzepatide

    A dual GIP and GLP-1 receptor agonist approved for type 2 diabetes and chronic weight management. FDA-approved prescription products containing Tirzepatide exist (Mounjaro, Zepbound). Compounded and research formulations are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness or quality.

U

V

  • Vial

    A small sealed glass container for a liquid or powder, closed with a rubber stopper and usually a crimped metal cap.

Get VialPal Free